Grace Therapeutics GRCE Cash Flow Statement (2018-2026)

NASDAQ GRCE
$2.14 -0.06 (-2.73%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
0.98M-3.78M-1.78M-4.52M-4.93M-3.89M-38.63M-4.02M-3.27M-2.39M-4.66M-2.62M-3.43M-4.16M0.12M-3.36M-0.94M-2.31M-1.18M-15.79M
Depreciation and Depletion (Quarter)
0.17M-0.06M0.01M0.01M0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Share-based Compensation (Quarter)
0.11M0.45M0.62M0.46M0.58M0.44M1.81M0.08M0.28M0.33M0.23M0.24M0.20M0.16M0.13M0.30M0.21M0.11M0.18M0.21M
Deferred Taxes (Quarter)
-0.21M0.89M-0.72M-0.85M-0.60M4.53M0.87M
Gains from Investment Securities (Quarter)
-3.44M-0.83M4.91M-0.01M1.83M-0.12M-1.68M-1.40M-0.36M1.18M-2.64M0.49M-1.43M0.04M
Asset Writedowns and Impairment (Quarter)
-0.25M0.41M13.53M
Non-cash Items (Quarter)
Change in Working Capital (Quarter)
2.60M0.68M-1.03M1.27M-1.13M0.04M
Change in Receivables (Quarter)
0.38M0.03M0.04M0.12M-0.24M-0.33M0.02M-0.11M-0.17M-0.11M
Change in Inventory (Quarter)
Change in Account Payables (Quarter)
-0.07M-1.45M-0.54M0.40M-0.06M0.91M0.08M-0.70M-0.37M0.71M-1.07M0.04M0.86M-0.90M
Change in Accured Expenses (Quarter)
-1.04M
Other Working Capital Changes (Quarter)
-1.27M1.41M-0.14M-0.01M-0.01M
Cash from Operations (Quarter)
-6.10M-4.58M-3.15M-5.43M-3.44M-3.72M-3.33M-6.24M-2.11M-1.89M-2.09M-3.60M-4.24M-4.12M-2.95M-1.80M-3.14M-2.23M-1.70M-3.22M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.17M-0.06M0.01M0.01M0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.00M0.01M0.02M
Sales of Property, Plant and Equipment (Quarter)
0.00M
Change in Acquisitions & Divestments (Quarter)
16.06M13.88M0.09M13.28M-0.10M5.00M6.57M
Cash from Investing Activities (Quarter)
2.84M0.56M0.01M13.26M-0.10M-5.00M4.99M0.11M-6.55M6.55M-0.01M0.01M
Financing Activities
Other financing activities (Quarter)
0.24M
Change in Capital Stock
Shares Issued (Quarter)
0.72M2.98M2.99M1.20M1.58M4.45M0.74M0.47M0.22M0.72M0.72M0.38M1.35M0.93M0.93M0.67M1.31M1.31M0.94M1.35M
Net Equity Issued and Repurchased (Quarter)
0.20M0.11M
Misc.
Cash from Financing Activities (Quarter)
0.20M0.11M7.36M14.03M-0.33M4.04M
Exchange Rate Effect (Quarter)
-0.98M-0.03M0.26M0.05M-0.22M0.30M-0.13M
Change in Cash (Quarter)
-4.05M-3.92M-2.67M8.04M-3.45M-8.69M1.63M-6.24M5.36M-8.45M4.46M-3.61M-4.24M-4.10M11.08M-2.13M-3.14M1.81M-1.70M-3.22M
Free Cash Flow (Quarter)
-6.10M-4.58M-3.15M-5.43M-3.44M-3.72M-3.33M-6.24M-2.11M-1.89M-2.11M-3.60M-4.24M-4.12M-2.95M-1.80M-3.14M-2.23M-1.70M-3.22M
Net Cash Flow (Quarter)
-3.27M-4.03M-3.13M8.03M-3.43M-8.72M1.67M-6.24M5.36M-8.45M4.46M-3.61M-4.24M-4.10M11.08M-2.13M-3.14M1.81M-1.70M-3.22M